Lapini A - Search Results

1

Gemcitabine plus docetaxel as first-line biweekly therapy in locally advanced and/or metastatic urothelial carcinoma: a phase II study.

Neri B, Vannini L, Giordano C, Grifoni R, Pantaleo P, Baldazzi V, Crisci A, Lapini A, Raugei A, Carini M. Neri B, et al. Among authors: lapini a. Anticancer Drugs. 2007 Nov;18(10):1207-11. doi: 10.1097/CAD.0b013e3282be8d5a. Anticancer Drugs. 2007. PMID: 17893522 Clinical Trial.

2

Gemcitabine plus cisplatin in adjuvant regimen for bladder cancer. Toxicity evaluation.

Meliani E, Lapini A, Serni S, Corvino C, Carini M. Meliani E, et al. Among authors: lapini a. Urol Int. 2003;71(1):37-40. doi: 10.1159/000071091. Urol Int. 2003. PMID: 12845258 Clinical Trial.

3

The impact of sunitinib-induced hypothyroidism on progression-free survival of metastatic renal cancer patients: a prospective single-center study.

Baldazzi V, Tassi R, Lapini A, Santomaggio C, Carini M, Mazzanti R. Baldazzi V, et al. Among authors: lapini a. Urol Oncol. 2012 Sep;30(5):704-10. doi: 10.1016/j.urolonc.2010.07.015. Epub 2010 Oct 2. Urol Oncol. 2012. PMID: 20884255 Clinical Trial.

4

Sunitinib-induced hyperparathyroidism: a possible mechanism to altered bone homeostasis.

Baldazzi V, Tassi R, Lapini A, Lunghi A, Garofoli E, Caruso S, Carini M, Mazzanti R. Baldazzi V, et al. Among authors: lapini a. Cancer. 2012 Jun 15;118(12):3165-72. doi: 10.1002/cncr.26435. Epub 2011 Sep 28. Cancer. 2012. PMID: 21956360 Free article.

5

Hyperlipidemia and hypothyroidism among metastatic renal cell carcinoma patients taking sunitinib malate. Related or unrelated adverse events?

Tassi R, Baldazzi V, Lapini A, Carini M, Mazzanti R. Tassi R, et al. Among authors: lapini a. Clin Genitourin Cancer. 2015 Apr;13(2):e101-5. doi: 10.1016/j.clgc.2014.08.009. Epub 2014 Sep 22. Clin Genitourin Cancer. 2015. PMID: 25450040

6

Simple enucleation for the treatment of renal cell carcinoma between 4 and 7 cm in greatest dimension: progression and long-term survival.

Carini M, Minervini A, Lapini A, Masieri L, Serni S. Carini M, et al. Among authors: lapini a. J Urol. 2006 Jun;175(6):2022-6; discussion 2026. doi: 10.1016/S0022-5347(06)00275-8. J Urol. 2006. PMID: 16697790

7

Simple enucleation for the treatment of PT1a renal cell carcinoma: our 20-year experience.

Carini M, Minervini A, Masieri L, Lapini A, Serni S. Carini M, et al. Among authors: lapini a. Eur Urol. 2006 Dec;50(6):1263-8; discussion 1269-71. doi: 10.1016/j.eururo.2006.05.022. Epub 2006 Jun 6. Eur Urol. 2006. PMID: 16787695

8

Progression and long-term survival after simple enucleation for the elective treatment of renal cell carcinoma: experience in 107 patients.

Lapini A, Serni S, Minervini A, Masieri L, Carini M. Lapini A, et al. J Urol. 2005 Jul;174(1):57-60; discussion 60. doi: 10.1097/01.ju.0000162019.45820.53. J Urol. 2005. PMID: 15947577

9

A proposed score for assessing progression in pT1 high-grade urothelial carcinoma of the bladder.

Raspollini MR, Minervini A, Lapini A, Lanzi F, Rotellini M, Baroni G, Carini M. Raspollini MR, et al. Among authors: lapini a. Appl Immunohistochem Mol Morphol. 2013 May;21(3):218-27. doi: 10.1097/PAI.0b013e31825f3264. Appl Immunohistochem Mol Morphol. 2013. PMID: 22820663

10

Cancer progression after anterograde radical prostatectomy for pathologic Gleason score 8 to 10 and influence of concomitant variables.

Serni S, Masieri L, Minervini A, Lapini A, Nesi G, Carini M. Serni S, et al. Among authors: lapini a. Urology. 2006 Feb;67(2):373-8. doi: 10.1016/j.urology.2005.08.023. Urology. 2006. PMID: 16461088

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

130 results

Search Page

Filters